Fas and FasL levels seem to be increased during brain ischemia [89], and interfering with the Fas signaling pathway using a blocking anti-FasL antibody markedly reduces death of neurons and improves functional recovery in animal models of stroke and spinal injury. The gene discussed is FASLG; the disease is stroke disorder.